Defining a non-eosinophilic inflammatory subtype in COPD: the role of CXCL9 and type 1 immune responses

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2025-04-17
DOI
https://doi.org/10.3389/fimmu.2025.1576849
Citations
1
Primary Topic
Asthma and respiratory diseases
Type
article
Field-Weighted Citation Impact
1.16

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Defining a non-eosinophilic inflammatory subtype in COPD: the role of CXCL9 and type 1 immune responses

Takehiro Hasegawa, Ling Yao, Huiping Li, Song Jiacui et al.
1 citations
Frontiers in Immunology
Asthma and respiratory diseases
1.16
article

Defining a non-eosinophilic inflammatory subtype in COPD: the role of CXCL9 and type 1 immune responses

Takehiro Hasegawa, Ling Yao, Huiping Li, Song Jiacui, Takami Kondo, Yin Chengsheng
article en
1 citations

Abstract

No abstract available for this paper.
Frontiers in ImmunologyVol. 16
Tongji University (CN), Sysmex (Germany) (DE), Shanghai Pulmonary Hospital (CN), Sysmex (Japan) (JP)
National Science Foundation, Sysmex Corporation
Openalex Percentile: Top 23%
Asthma and respiratory diseases
1.16
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.